Epidermal growth factor (EGF) was initially described as a polypeptide hormone, isolated from the mouse submaxillary gland, that caused precocious eyelid opening and tooth eruption when injected into newborn mice. Both zffects are a consequence of enhanced epidermal growth and keratinization. EGF also stimulates the proliferation of keratinocytes and fibroblasts in culture. For his discovery and subsequent work Stanley Cohen has recently been awarded the Nobel Prize (Cohen, 1987) . Mouse EGF is a 53 amino acid polypeptide with three disulphide-bridged loops (Savage et al., 1972 (Savage et al., , 1973 . The human homologue is the same size and is identical to the gastric anti-secretory hormone urogastrone (Gregory, 1975) .
The biological responses to EGF are mediated by a membrane receptor, a 170 kDa protein with an extracellular ligand binding domain and an intracellular domain possessing tyrosine kinase activity (Hunter, 1984) . EGF binding promotes receptor dimerization and activation of the kinase Abbreviations used: EGF, epidermal growth factor; TGF, transforming growth factor; VGF, SFGF, and MGF, growth factors from vaccinia, Shope fibroma virus and myxoma virus, respectively; MCV, Molluscum coniagiosurn virus. domain, substrates for which include lipocortin and the receptor itself (Yarden & Schlessinger, 1987) . Other responses to EGF include enhanced Na+ /H + antiport activity, enhanced release of Ca2+ from intra-and extracellular stores, enhanced turnover of phosphoinositides in A431 cells (but not in 3T3 cells) and a mitogenic response with induction of c-fos and c-myc expression, culminating in DNA synthesis (Carpenter & Cohen, 1979; Schlessinger el al., 1983) . After binding, the ligand-receptor complex is internalized and proteolytically degraded; this processing is necessary for induction of the late response of DNA synthesis (Schaudies et a [., 1987) . The kinase domain is cruciai to the function of the EGF receptor, since mutagenesis of its ATP binding site abolishes all early and late responses to EGF (Chen et af., 1987) . The product of the oncogene v-erbB is homologous to part of the EGF receptor and thought to be a truncated version of the chicken homologue: it lacks the ligand binding and autophosphorylation domains and is constitutively active (Lax et al., 1985) . Over-expression of the EGF receptor is associated with a high proportion of squamous cell carcinomas and has also been detected in other tumour types (Ozanne et al., 1986) . In normal epidermis, EGF receptors occur predominantly in the basal cell layer (Nanney et al., 1984) .
The major site of synthesis in the mouse is the submaxillary gland, where EGF is initially synthesized as a 128 kDa transmembrane precursor from which it is proteolytically cleaved (Gray et al., 1983) . The precursor possesses Vol. 16
It is also made in the kidney cortex, but is not processed in this tissue (Rall et al., 1985) . Based on homology to the receptor for low density lipoprotein, the precursor has been postulated to be a receptor for an as yet unidentified ligand; this may explain its presence in kidney (Pfeffer & Ullrich, 1985) . Following retroviral or chemical transformation, many cells lose their ability to bind EGF owing to the production by these cells of an EGF-related polypeptide, a-transforming growth factor (TGF) (De Larco & Todaro, 1978) . In terms of its primary amino acid sequence and its ability to bind to the EGF receptor with a similar affinity and elicit a similar response, TGF is structurally and functionally homologous to EGF (Sporn & Todaro, 1980) . TGF is a 50 amino acid polypeptide and is cleaved from a 17 kDa transmembrane precursor (Teixido et al., 1987) . In many biological assay systems the response to EGF and TGF is identical; however, TGF is more potent at stimulating hair follicle development, bone resorption, angiogenesis and keratinocyte migration. It is synthesized early in mouse fetal development and is present throughout the epidermis of neonatal and adult human skin, where it is synthesized by keratinocytes (reviewed by Derynck, 1986; Barrandon & Green, 1987; Coffey et al., 1987) . TGF is autoinduced and so must normally be held in check by some other control mechanism. It may play a role in vivo in response to wounding (Coffey et al., 1987) . In transformed cells inappropriate expression of TGF may act to stimulate cell growth by an autocrine or paracrine mechanism (Rosenthal et al., 1986) . In agreement with this hypothesis, TGF is synthesized in many solid tumours, such as squamous cell carcinomas, which overexpress the EGF receptor .
The orthopoxvirus vaccinia has been shown to synthesize a polypeptide (approximately 77 amino acids), present in the conditioned medium of infected cells, with structural and functional homology to EGF/TGF (Stroobant et al., 1985; Twardzik et al., 1985) . This growth factor (VGF) is released from a putative 140 amino acid transmembrane precursor synthesized early in viral infection. In contrast to mature EGF and TGF, VGF is glycosylated. The role of VGF in vaccinia viral infection, which is cytolytic, is unknown. Saturation of EGF receptors causes only a small decrease in infectivity (Eppstein et al., 1985) and the fact that vaccinia can infect a cell line lacking EGF receptors argues against a role for VGF in mediating viral attachment (Stroobant el al., 1985) . It may be that VGF works to enhance the metabolic activity of infected and neighbouring cells and so create a more favourable environment for viral replication. However, the possibility of mitogenic stimulation by such a growth factor is of interest given the association of proliferative disease with other poxviruses. Recently, the poxvirus Shope fibroma virus, associated with a widespread proliferative disease in rabbits, and the poxvirus myxoma, the agent of myxomatosis, have been shown to encode analogous polypeptides (SFGF and MGF) (Chang et al., 1987; Upton et al., 1987) . However, SFGF and MGF are apparently not synthesized as transmembrane precursors. Other poxviruses responsible for the induction of cell proliferation include Yaba monkey tumour virus, which causes fibromas in monkeys, and Molluscum contagiositm virus. The latter causes benign skin tumours in man: viral replication occurs in the squamous cell layer and the basal cell proliferation rate is enhanced (Postlethwaite, 1 970) . Fig. 1 shows the aligned sequences of the members of the EGF-like growth factor family. In addition to the overall conservation of Cys and Gly residues there is a striking level of conservation of amino acids within the third disulphide loop (residues 33-42), implying an important functional role for this region of the molecule (see below). Although EGF, TGF and the poxviral growth factors are structurally and functionally homologous, there is no significant homology at the nucleotide level between the genes encoding them. The presence of EGF-like domains in other proteins has also been noted: these include several mammalian serum coagulation proteins (clotting factors IX, X, XII, C and Z; tissue plasminogen activator) and two non-mammalian developmental Chang et al. (1987) and Upton et al. (1987) . 
The disulphide bonds (bold lines) and hydrogen bonds (dashed lines) involved in B-
sheet and B-turn formation are indicated. The residues identified are those highly conserved among members of the EGF-like growth factor family. Adapted from Cooke et al. ( 1987) .
proteins thought to be involved in intercellular communication (products of the Drosophilu rnelarioguster Notch gene and the Cuetiorhuhditis elegutis liri-12 gene) (Blomquist eta/., 1984; Greenwald, 1985; Wharton et al., 1985) . These sequences are aligned in Fig. 2 . The two developmental
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proteins possess tandem repititions of this EGF-like domain, reminiscent of the structure of the EGF precursor itself; one such repeat of the Notch product contains all of the conserved residues in the putative receptor-binding third disulphide loop of the EGF-like growth factors and so may functionally interact with the Ilrosophila homologue of the EGF receptor. It is conceivable that the clotting factors may also bind to the EGF receptor; this could have a physiologically significant role to play in the induction of the wound response, particularly if they bound as their activated forms only. The solution structure of mouse EGF and human EGF has been determined by proton n.m.r.; both form two regions of disulphide-bridged anti-parallel @-sheet which divide the molecule into two structural domains: residues 1-32 and 33-53 (Montelione et al., 1986; Cooke et al., 1987 ) (see Fig.  3 ). Efforts to identify regions of the EGF molecule responsible for receptor binding have involved the use of short synthetic peptides. A peptide corresponding to human EGF residues 20-3 1 shows binding to the receptor with an affinity > 104-fold lower than EGF itself and also elicits receptor autophosphorylation (Komoriya et al., 1984) . A peptide corresponding to residues 34-43 of TGF (equivalent to residues 33-42 of E G F ) showed an affinity 50-fold lower than EGF or TGF, but had no other activity . These peptides occur in the two regions of @-sheet: both bind antibody raised to the whole molecule suggesting that they correspond to surface epitopes. As noted above, sequence comparison of these regions with the other EGFlike growth factors indicates a high level of conservation associated with the region corresponding to the latter peptide while there is no conservation in the former region with the exception of the cysteine residues. Assuming that sequence conservation reflects functional conservation this argues in favour of the third disulphide loop mediating binding to the EGF receptor. Additional evidence in favour of this is that EGF cleaved with cyanogen bromide at Met-2 1 still binds with 10% the affinity of EGF and induces some early responses although it is not mitogenic (Yarden et a[., 1982) . The structure outlined above could be adopted by all members of the EGF family; all possess the six cysteine residues involved in disulphide bridge formation and such variations in size that occur (i.e. relative insertions and deletions) are positioned in regions of the molecule not involved in @-sheet formation (e.g. the insertion of three amino acids in SFGF relative to EGF positions 27-28 occurs in the loop between @-sheet strands). Glycosylation of VGF also does not disrupt the structure.
We are addressing the question as to whether the poxvirus Molluscum contagiosum (MCV ) induces skin tumour formation by means of an EGF-like polypeptide, analogous to VGF. It is conceivable that high levels of such a growth factor could be tumorigenic by over-riding the normal control mechanisms present in skin. Thus viral replication in the squamous cell layer of the epidermis with secretion of an EGF homologue is a model by which basal cell replication might be enhanced, with subsequent tumour formation. MCV cannot be cultured in vitro and so the method we have adopted has been to search for a viral gene encoding such a factor. DNA probes for EGF and VGF do not cross-hybridize with MCV DNA: this is not unexpected from the lack of nucleotide conservation between those genes that have been sequenced. We have thus used as a probe a degenerate synthetic oligonucleotide capable of detecting DNA sequences encoding the conserved third disulphide loop of the EGF family which is thought to mediate receptor binding (see above). Such an approach was also used to identify the SFGF gene in Shope fibroma virus DNA. We have reported that MCV does indeed have the potential to encode such a peptide (Porter & Archard, 1987) . Nucleotide sequencing of this region of the viral genome is in progress.
